Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee
Clinical trial NCT00979953 · COMPLETED
Trial details
- NCT number
- NCT00979953
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-04-01
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.